Jen Schwartz, senior editor and blockchain expert at Scientific American, talks the magazine's latest articles on the rise of Bitcoin and what impact cryptocurrencies may have on our future. Schwartz digs into how what people currently love about cryptocurrency could be seen as a threat in the future. One of the positives of cryptocurrency is its lack of centralization and regulation. But if entire countries begin to use it as their national currency, everything citizens purchase will be seen by the government. Schwartz digs into some of the biggest questions around the rise of Bitcoin today - how will it benefit everyday people in the long-term? What happens if the bubble bursts, and what will that do for investor trust in cryptocurrency? Schwartz gives her advice for people looking to possibly invest in Bitcoin, adding that if you are not concerned with losing money and you're looking to experiment, make the investment. If risk is a big concern for you, investing in crypto right now may not be the right move.

Share:
More In Business
April Hiring Gains Reflect a Still-Resilient US Job Market
America’s employers added a healthy 253,000 jobs in April, evidence of a labor market that still shows surprising strength despite rising interest rates, chronically high inflation and a banking crisis that could weaken the economy.
Celebrating AAPI: Entrepreneur Discusses Bringing Japanese Snacks to the World
Danny Taing, founder and CEO of Bokksu, joined Cheddar News to discuss his path on how he became an entrepreneur to launch a company that delivers artisanal Japanese snacks. "When I moved back from Japan to New York, I had this bit of reverse culture shock ... a lot of people had somewhat of a one-dimensional view of Japan ... they saw this country where people ate sushi every day ... none of that is true," he said.
WSJ: Food Workers Union Opposing Kroger-Albertson's Deal
The United Food and Commercial Workers union, one of the country's largest, opposed the planned merger between grocery chains Kroger and Albertson's, according to The Wall Street Journal, citing concerns about lack of information and the potential viability of stores upon closing.
Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Load More